Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib for HER2-Mutant, Recurrent/Metastatic Cervical Cancer at the ESMO...
LOS ANGELES--(BUSINESS WIRE)--Sep 11, 2022--
LOS ANGELES--(BUSINESS WIRE)--Sep 11, 2022--